Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voluven versus lactated Ringer's for postoperative intravascular volume replacement after partial hepatectomy in hepatocellular carcinoma
ChiCTR-TRC-10000790Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2010
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of Volulyte and lactated ringer's solution in hepatocellular carcinoma (HCC) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Biochemical indices of liver function, Plasma osmolality and 1 more. Started Apr 2010; status: completed.
02
Drugs
Volulytelactated ringer's solution
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on ChiCTR-TRC-10000790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000790.